Accredited Investors Inc. Dexcom Inc Transaction History

Accredited Investors Inc.

$1.65 Billion
Q4 2024

A detailed history of Accredited Investors Inc. transactions in Dexcom Inc stock. As of the latest transaction made, Accredited Investors Inc. holds 4,377 shares of DXCM stock, worth $386,795. This represents 0.02% of its overall portfolio holdings.

Number of Shares

4,377

Previous 4,507 2.88%

Holding current value

$386,795

Previous $302,000 12.58%

% of portfolio

0.02%

Previous 0.02%

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 13, 2025	SELL	$65.68 - $81.01 $8,538 - $10,531	-130 Reduced 2.88%	4,377 $340,000
Q3 2024 Nov 06, 2024	SELL	$64.0 - $116.06 $46,656 - $84,607	-729 Reduced 13.92%	4,507 $302,000
Q3 2024 Nov 05, 2024	BUY	$64.0 - $116.06 $46,656 - $84,607	729 Added 16.17%	5,236 $350,000
Q2 2024 Jul 19, 2024	SELL	$110.31 - $140.45 $15,002 - $19,101	-136 Reduced 2.93%	4,507 $511,000
Q1 2024 May 14, 2024	BUY	$114.22 - $140.1 $14,848 - $18,213	130 Added 2.88%	4,643 $643,000
Q2 2023 Aug 03, 2023	SELL	$112.47 - $130.98 $43,750 - $50,951	-389 Reduced 7.94%	4,513 $579,000
Q4 2022 Feb 07, 2023	BUY	$84.98 - $122.67 $169 - $245	2 Added 0.04%	4,902 $555,000
Q3 2022 Nov 08, 2022	SELL	$76.35 - $94.18 $7,634 - $9,418	-100 Reduced 2.0%	4,900 $395,000
Q2 2022 Jul 21, 2022	BUY	$67.99 - $132.89 $254,826 - $498,071	3,748 Added 299.36%	5,000 $373,000
Q1 2022 May 06, 2022	BUY	$94.08 - $130.2 $376 - $520	4 Added 0.32%	1,252 $641,000
Q3 2021 Nov 12, 2021	SELL	$106.71 - $143.18 $2,881 - $3,865	-27 Reduced 2.12%	1,248 $682,000
Q2 2021 Jul 30, 2021	SELL	$80.99 - $107.93 $4,616 - $6,152	-57 Reduced 4.28%	1,275 $544,000
Q1 2021 Apr 16, 2021	SELL	$84.79 - $104.74 $21,451 - $26,499	-253 Reduced 15.96%	1,332 $479,000
Q3 2020 Nov 05, 2020	SELL	$95.51 - $112.95 $6,781 - $8,019	-71 Reduced 4.29%	1,585 $163,000
Q2 2020 Jul 29, 2020	SELL	$62.68 - $105.34 $7,270 - $12,219	-116 Reduced 6.55%	1,656 $671,000
Q1 2020 May 15, 2020	SELL	$47.79 - $75.63 $19,307 - $30,554	-404 Reduced 18.57%	1,772 $477,000
Q2 2019 Aug 13, 2019	SELL	$27.84 - $38.92 $3,480 - $4,865	-125 Reduced 5.43%	2,176 $0
Q1 2019 Apr 17, 2019	BUY	$28.07 - $38.18 $5,417 - $7,368	193 Added 9.16%	2,301 $274,000
Q4 2018 Feb 13, 2019	SELL	$26.99 - $37.37 $6,990 - $9,678	-259 Reduced 10.94%	2,108 $253,000
Q2 2018 Jul 31, 2018	BUY	$17.54 - $25.22 $41,517 - $59,695	2,367 New	2,367 $225,000

Others Institutions Holding DXCM

# of Institutions

1,085

Shares Held

352M

Call Options Held

8.45M

Put Options Held

5.75M

View Full List

About DEXCOM INC

Ticker DXCM
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 386,257,984
Market Cap $34.1B
Description
DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring (CGM) systems in the United States and internationally. The company provides its systems for use by people with diabetes, as well as for use by healthcare providers. Its products include DexCom G6, an integrated CGM ...

More about DXCM

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Accredited Investors Inc., based on Form 13F filings with the SEC.

News

Stay updated on Accredited Investors Inc. with notifications on news.

Account

Accredited Investors Inc. Dexcom Inc Transaction History